Benign prostatic hyperplasia: medical management considering sexual function and prostate cancer.

Statements and opinions expressed in this supplement are those of the authors and not necessarily those of the American Osteopathic Association, JAOA, the editors or the Editorial Advisory Board, or the institutions with which the authors are affiliated, unless expressly stated. This supplement to the JAOA is designated by the Division of Continuing Medical Education of the American Osteopathic Association to carry 2 hours of Category 1-B credit for osteopathic physicians who read it and return the completed posttest. All editorial content is developed independently by the American Osteopathic Association in accordance with the Food and Drug Administration’s Guidelines for Continuing Medical Education Programs.